161 related articles for article (PubMed ID: 6271727)
1. Antibacteroides and beta-lactamase inhibitory activities of moxalactam.
Fu KP; Neu HC
J Antimicrob Chemother; 1981 Oct; 8(4):337-41. PubMed ID: 6271727
[No Abstract] [Full Text] [Related]
2. Comparative antibacterial activities of 7 alpha-methoxy cephalosporins and 7 beta-methoxyiminoacetamido cephalosporins against Bacteroides fragilis.
Kesado T; Watanabe K; Asahi Y; Isono M; Ueno K
Antimicrob Agents Chemother; 1984 Jan; 25(1):131-3. PubMed ID: 6322676
[TBL] [Abstract][Full Text] [Related]
3. The activity of five cephalosporins against Bacteroides fragilis.
Ryan RW; Kwasnik I; Tilton RC
Ann Clin Lab Sci; 1982; 12(1):32-4. PubMed ID: 6279014
[No Abstract] [Full Text] [Related]
4. Comparison of the beta-lactamase stability and the in-vitro activity of cefoperazone, cefotaxime, cefsulodin, ceftazidime, moxalactam and ceftriaxone against Pseudomonas aeruginosa.
Livermore DM; Williams RJ; Williams JD
J Antimicrob Chemother; 1981 Oct; 8(4):323-31. PubMed ID: 6271726
[No Abstract] [Full Text] [Related]
5. Cephamycin inactivation due to enzymatic hydrolysis by beta-lactamase from Bacteroides fragilis.
Yotsuji A; Minami S; Kakizawa H; Yasuda T; Takai A; Saikawa I; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1985 Dec; 28(6):773-7. PubMed ID: 3878690
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of N-formimidoyl thienamycin, moxalactam, and other new beta-lactam agents against Bacteroides fragilis: contribution of beta-lactamase to resistance.
Brown JE; Del Bene VE; Collins CD
Antimicrob Agents Chemother; 1981 Feb; 19(2):248-52. PubMed ID: 6214986
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity, beta-lactamase stability and beta-lactamase inhibition of cefotetan and other 7-alpha-methoxy beta-lactam antimicrobials.
Jones RN; Wilson HW
Diagn Microbiol Infect Dis; 1983 Mar; 1(1):71-83. PubMed ID: 6323095
[TBL] [Abstract][Full Text] [Related]
8. Activity and specific beta-lactamase susceptibility of cefoperazone and moxalactam. Comparison with other cephalosporins.
Mouton RP; Bongaerts GP; van Gestel M; Bruggeman-Ogle KM
Chemotherapy; 1981; 27(5):318-24. PubMed ID: 6455258
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of antimicrobial activity and stability to beta-lactamases of cefoperazone, cefotaxime, lamoxactam and ceftriaxon].
Baumgärtner M; Grehn M; Wundt W
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):208-21. PubMed ID: 6289564
[TBL] [Abstract][Full Text] [Related]
10. Enzyme-mediated resistance of Bacteroides fragilis to moxalactam.
Maskell JP; Nasu M
Lancet; 1981 Mar; 1(8222):733. PubMed ID: 6110951
[No Abstract] [Full Text] [Related]
11. Comparative in vitro activity of first, second and third generation cephalosporins.
Forsgren A
Acta Pathol Microbiol Scand B; 1981 Aug; 89(4):221-5. PubMed ID: 6274143
[TBL] [Abstract][Full Text] [Related]
12. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
[TBL] [Abstract][Full Text] [Related]
13. Effect of beta-lactamase inhibitors on the antimicrobial activity of cefoperazone, cefotaxime, and ceftizoxime against aerobic and anaerobic beta-lactamase producing bacteria.
Fuchs PC; Jones RN; Barry AL
Diagn Microbiol Infect Dis; 1987 Sep; 8(1):61-5. PubMed ID: 3501975
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of MK0787 (N-formimidoyl thienamycin) and other beta-lactam compounds against Bacteroides spp.
Nasu M; Maskell JP; Williams RJ; Williams JD
Antimicrob Agents Chemother; 1981 Oct; 20(4):433-6. PubMed ID: 6282191
[TBL] [Abstract][Full Text] [Related]
15. Combination of mezlocillin and azlocillin with cephalosporin antibiotics: cefoxitin, cefoperazone, cefotaxime and moxalactam.
Neu HC; Labthavikul P
J Antimicrob Chemother; 1982 Jan; 9 Suppl A():101-6. PubMed ID: 6281229
[No Abstract] [Full Text] [Related]
16. In vitro antimicrobial activity of cefoperazone, cefotaxime, moxalactam (LY127935), azlocillin, mezlocillin, and other beta-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including beta-lactamase-producing strains.
Baker CN; Thornsberry C; Jones RN
Antimicrob Agents Chemother; 1980 Apr; 17(4):757-61. PubMed ID: 6249195
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria.
Borobio MV; Aznar J; Jimenez R; Garcia F; Perea EJ
Antimicrob Agents Chemother; 1980 Feb; 17(2):129-31. PubMed ID: 6247966
[TBL] [Abstract][Full Text] [Related]
18. Effect of inoculum size and beta-lactamase production on in vitro activity of new cephalosporins against Haemophilus species.
Bulger RR; Washington JA
Antimicrob Agents Chemother; 1980 Mar; 17(3):393-6. PubMed ID: 6448575
[TBL] [Abstract][Full Text] [Related]
19. Inoculum size effect on the MIC of cefoperazone, moxalactam, cefotaxime, cefoxitin and cephalothin for 118 strains of Haemophilus influenzae including 'tolerant' micro-organisms.
Simard P; Bergeron MG
J Antimicrob Chemother; 1982 Nov; 10(5):397-402. PubMed ID: 6294044
[No Abstract] [Full Text] [Related]
20. [Moxalactam: an inactivator of beta-lactamases].
Labia R
Sem Hop; 1983 Jun; 59(26):1959-62. PubMed ID: 6310786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
